NasdaqGM:VCELBiotechs
Vericel (VCEL) Stock Faces Valuation Scrutiny After Record Revenue Growth
Vericel just gave investors a sentiment check. The stock slipped about 3.5% to US$45.96 after the Q2 print, even though the company reported record quarterly revenue of US$77.5m and positive net income of US$2.2m. The key point is not a blowout or a blowup; it is a growth story trading at a very rich P/E near 97x.
In other words, this is a high-expectation stock where even solid numbers can trigger a rethink. The price move reflects nerves, while the earnings reflect execution. The gap...